Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Jun 27, 2024; 16(6): 1709-1716
Published online Jun 27, 2024. doi: 10.4240/wjgs.v16.i6.1709
Published online Jun 27, 2024. doi: 10.4240/wjgs.v16.i6.1709
Table 1 Comparison of clinical data between the two groups
| Index | Study group (n = 45) | Control group (n = 45) | χ2/t | P value |
| Sex | 0.044 | 0.832 | ||
| Male | 25 | 24 | ||
| Female | 20 | 21 | ||
| Age (yr) | 48.80 ± 9.50 | 49.50 ± 9.80 | 0.639 | 0.524 |
| BMI (kg/m2) | 23.50 ± 3.12 | 24.01 ± 2.85 | 0.796 | 0.427 |
| Complications (n) | 0.795 | 0.672 | ||
| Diabetes | 4 | 5 | ||
| Hypertension | 18 | 14 | ||
| Hyperlipidemia | 9 | 11 | ||
| Arrhythmia | 2 | 1 | ||
| Smoking history (n) | 0.189 | 0.664 | ||
| Yes | 16 | 18 | ||
| No | 29 | 27 | ||
| Drinking history (n) | 0.179 | 0.673 | ||
| Yes | 20 | 22 | ||
| No | 25 | 23 |
- Citation: Wang T, Zhang LY. Evaluation of oxaliplatin and tigio combination therapy in locally advanced gastric cancer. World J Gastrointest Surg 2024; 16(6): 1709-1716
- URL: https://www.wjgnet.com/1948-9366/full/v16/i6/1709.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i6.1709